Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07116538Not ApplicableNot Yet Recruiting

Implementation and Effects of Nishauri on HIV Treatment Outcomes Among Men

Role: lead

NCT03942536Completed

The MOMENTUM Study (Monitoring Maternal Emergency Navigation and Triage on Mfangano

Role: collaborator

NCT03782272Not ApplicableTerminated

Safety, Acceptability, and Feasibility of Enterade®

Role: collaborator

NCT02073149Phase 2Completed

Safe and Efficacious Iron for Children in Kenya

Role: collaborator

NCT02162238Not ApplicableCompleted

Assessment of Zinc Intake From Enriched Water and Other Dietary Sources in Kisumu, Kenya

Role: collaborator

All 5 trials loaded